Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
TDCX Adds 14% On Improved Quarterly Results, Outlook
-
Cryptos Firm Amidst FOMC Minutes, Economic Data
-
‘Diamond Hands’ Tesla Still HODLing Over 10,000 BTC, Q4 2022 Report Reveals
-
Despite Small Wins, Bitcoin Could Tumble To $20,000 By The End Of October
-
Bitcoin Emerges as 'Blue Chip' Crypto Amid Market Uncertainty